{
    "id": 26502,
    "fullName": "BRD2 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "BRD2 positive indicates the presence of the BRD2 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 6046,
        "geneSymbol": "BRD2",
        "terms": [
            "BRD2",
            "BRD2-IT1",
            "D6S113E",
            "FSH",
            "FSRG1",
            "NAT",
            "O27.1.1",
            "RING3",
            "RNF3"
        ]
    },
    "variant": "positive",
    "createDate": "05/02/2017",
    "updateDate": "05/02/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10854,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BETd-246 induced degradation of Brd2, Brd3, and Brd4, resulted in apoptosis of triple-receptor negative breast cancer cell lines in culture, and inhibited tumor growth in cell line xenograft models (PMID: 28209615).",
            "molecularProfile": {
                "id": 27776,
                "profileName": "BRD2 pos BRD3 pos BRD4 pos"
            },
            "therapy": {
                "id": 5603,
                "therapyName": "BETd-246",
                "synonyms": null
            },
            "indication": {
                "id": 60081,
                "name": "triple-receptor negative breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8792,
                    "pubMedId": 28209615,
                    "title": "Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28209615"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27741,
            "profileName": "BRD2 positive",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27776,
            "profileName": "BRD2 pos BRD3 pos BRD4 pos",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}